Increasing Prevalence Of Motion Sickness Is Expected To Drive Growth Of The Scopolamine Market

According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. Thus, increasing number of population suffering from stress and anxiety disorder are expected to fuel growth of the global scopolamine market.

Use of scopolamine in Alzheimer's disease may prove useful as a diagnostic or staging test in the evaluation of the cholinergic system in dementia, which provides opportunities to the researchers to explore application of these drugs for other neurological disorders, which in turn is driving the market growth over the forecast period.

Click To Continue Reading On Scopolamine Market

However, abuse of these drugs in various regions illegally, may restrict growth of the scopolamine market during the forecast period. For instance, this drug is more common and easily available in Colombia, where it is used to make victims carry out sexual assaults and robberies. Furthermore, online availability of this drugs at low cost, which are abuse by sexual predators and robbers frequently in the various European regions (in UK, scopolamine can be bought online for only US$ 12.8) might bring stringent regulations against the manufacturing and marketing of this drug in the near future which may affected growth of the scopolamine market.

Scopolamine Market- Regional Analysis

Scopolamine market is segmented into six major regions- North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing consumption of unhealthy food leading to obesity and other stomach related infections act as one of the major factors driving growth of the scopolamine market in North America region. According to an article published in the Brandon Gaille, in 2017, junk food accounts for 28.8% of the total caloric intake of an average American. Consumption of unhealthy food in large quantity increases the risk of developing irritable bowel syndrome, which is acting as a driving factor for the global scopolamine market growth.

The Asia Pacific region is estimated to witness significant growth in the scopolamine market, owing to presence of small and medium size companies, increased expenditure on healthcare, and growing medical tourism for surgeries as transdermal scopolamine has been used frequently during surgeries to recover from anesthesia induced vomiting and nausea.

Get The Holistic SAMPLE With Research Methodology:

https://www.coherentmarketinsights.com/insight/request-sample/1965

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherenttimes.org

This release was published on openPR.